Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 210 articles:
HTML format



Single Articles


    January 2021
  1. KREIS I, Biegler R, Tjelmeland H, Mittner M, et al
    Overestimation of volatility in schizophrenia and autism? A comparative study using a probabilistic reasoning task.
    PLoS One. 2021;16:e0244975.
    PubMed     Abstract available


  2. REEVE S, Sheaves B, Freeman D
    Excessive sleepiness in patients with psychosis: An initial investigation.
    PLoS One. 2021;16:e0245301.
    PubMed     Abstract available


  3. PRESTA V, Paraboschi F, Marsella F, Lucarini V, et al
    Posture and gait in the early course of schizophrenia.
    PLoS One. 2021;16:e0245661.
    PubMed     Abstract available


  4. FORNS J, Layton JB, Bartsch J, Turner ME, et al
    Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
    PLoS One. 2021;16:e0246121.
    PubMed     Abstract available


  5. ASHER L, Birhane R, Teferra S, Milkias B, et al
    "Like a doctor, like a brother": Achieving competence amongst lay health workers delivering community-based rehabilitation for people with schizophrenia in Ethiopia.
    PLoS One. 2021;16:e0246158.
    PubMed     Abstract available


  6. CROFT J, Martin D, Madley-Dowd P, Strelchuk D, et al
    Childhood trauma and cognitive biases associated with psychosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0246948.
    PubMed     Abstract available


  7. MANTRI S, Klawson E, Albert S, Rapoport R, et al
    The experience of care partners of patients with Parkinson's disease psychosis.
    PLoS One. 2021;16:e0248968.
    PubMed     Abstract available


  8. JAWORSKI M, Panczyk M, Sliwczynski A, Brzozowska M, et al
    Schizophrenic patients with type 2 diabetes: An 8-year population-based observational study.
    PLoS One. 2021;16:e0248407.
    PubMed     Abstract available


  9. HINOJOSA-MARQUES L, Monsonet M, Kwapil TR, Barrantes-Vidal N, et al
    The impact of family environment on self-esteem and symptoms in early psychosis.
    PLoS One. 2021;16:e0249721.
    PubMed     Abstract available


  10. MAKI S, Nagai K, Ando S, Tamakoshi K, et al
    Structure and predictors of in-hospital nursing care leading to reduction in early readmission among patients with schizophrenia in Japan: A cross-sectional study.
    PLoS One. 2021;16:e0250771.
    PubMed     Abstract available


  11. WENG S, Wang B, Li M, Chao S, et al
    Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
    PLoS One. 2021;16:e0249997.
    PubMed     Abstract available


  12. HAYASHI N, Igarashi Y, Harima H
    Delusion progression process from the perspective of patients with psychoses: A descriptive study based on the primary delusion concept of Karl Jaspers.
    PLoS One. 2021;16:e0250766.
    PubMed     Abstract available


  13. ROSEN DL, Travers D
    Emergency department visits among patients transported by law enforcement officers.
    PLoS One. 2021;16:e0244679.
    PubMed     Abstract available


  14. KIM K, Duc NT, Choi M, Lee B, et al
    EEG microstate features for schizophrenia classification.
    PLoS One. 2021;16:e0251842.
    PubMed     Abstract available


  15. KRONBICHLER L, Stelzig-Scholer R, Lenger M, Weber S, et al
    Preserved intention understanding during moral judgments in schizophrenia.
    PLoS One. 2021;16:e0251180.
    PubMed     Abstract available


  16. LINCOLN SH, Johnson T, Kim S, Edenbaum E, et al
    Psychosis proneness, loneliness, and hallucinations in nonclinical individuals.
    PLoS One. 2021;16:e0251753.
    PubMed     Abstract available


  17. KOBORI A, Miyashita M, Miyano Y, Suzuki K, et al
    Advanced glycation end products and cognitive impairment in schizophrenia.
    PLoS One. 2021;16:e0251283.
    PubMed     Abstract available


  18. KURUKGY JL, Bourgin J, Benoit JP, Guessoum SB, et al
    Implementing organicity investigations in early psychosis: Spreading expertise.
    PLoS One. 2021;16:e0252610.
    PubMed     Abstract available


  19. NOROVSAMBUU O, Tsend-Ayush A, Lkhagvasuren N, Jav S, et al
    Main characteristics of dermatoglypics associated with schizophrenia and its clinical subtypes.
    PLoS One. 2021;16:e0252831.
    PubMed     Abstract available


  20. SCHILLING TM, Bossert M, Konig M, Wirtz G, et al
    Acute effects of a single dose of 2 mA of anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex on executive functions in patients with schizophrenia-A randomized controlled trial.
    PLoS One. 2021;16:e0254695.
    PubMed     Abstract available


    January 2020
  21. CERNIS E, Freeman D, Ehlers A
    Describing the indescribable: A qualitative study of dissociative experiences in psychosis.
    PLoS One. 2020;15:e0229091.
    PubMed     Abstract available


  22. DESALEGN D, Girma S, Abdeta T
    Quality of life and its association with psychiatric symptoms and socio-demographic characteristics among people with schizophrenia: A hospital-based cross-sectional study.
    PLoS One. 2020;15:e0229514.
    PubMed     Abstract available


  23. MARUTANI T, Chhim S, Nishio A, Nosaki A, et al
    Quality of life and its social determinants for patients with schizophrenia and family caregivers in Cambodia.
    PLoS One. 2020;15:e0229643.
    PubMed     Abstract available


  24. PAROLA A, Salvini R, Gabbatore I, Colle L, et al
    Pragmatics, Theory of Mind and executive functions in schizophrenia: Disentangling the puzzle using machine learning.
    PLoS One. 2020;15:e0229603.
    PubMed     Abstract available


  25. SEILLIER A, Martinez AA, Giuffrida A
    Differential effects of Delta9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model.
    PLoS One. 2020;15:e0230238.
    PubMed     Abstract available


  26. FOSSE R, Laroi F
    Quantifying auditory impressions in dreams in order to assess the relevance of dreaming as a model for psychosis.
    PLoS One. 2020;15:e0230212.
    PubMed     Abstract available


  27. CHAVEZ-BALDINI U, Wichers M, Reininghaus U, Wigman JTW, et al
    Expressive suppression in psychosis: The association with social context.
    PLoS One. 2020;15:e0230102.
    PubMed     Abstract available


  28. LATORRE V, Papazacharias A, Lorusso M, Nappi G, et al
    Improving the "real life" management of schizophrenia spectrum disorders by LAI antipsychotics: A one-year mirror-image retrospective study in community mental health services.
    PLoS One. 2020;15:e0230051.
    PubMed     Abstract available


  29. DENIS F, Goueslard K, Siu-Paredes F, Amador G, et al
    Oral health treatment habits of people with schizophrenia in France: A retrospective cohort study.
    PLoS One. 2020;15:e0229946.
    PubMed     Abstract available


  30. YANG YJ, Luo T, Zhao Y, Jiang SZ, et al
    Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia.
    PLoS One. 2020;15:e0226688.
    PubMed     Abstract available


  31. MONTAG C, Schoner J, Speck LG, Just S, et al
    Peripheral oxytocin is inversely correlated with cognitive, but not emotional empathy in schizophrenia.
    PLoS One. 2020;15:e0231257.
    PubMed     Abstract available



  32. Correction: Quality of life and its social determinants for patients with schizophrenia and family caregivers in Cambodia.
    PLoS One. 2020;15:e0232434.
    PubMed     Abstract available


  33. HEROLD CJ, Essig M, Schroder J
    Neurological soft signs (NSS) and brain morphology in patients with chronic schizophrenia and healthy controls.
    PLoS One. 2020;15:e0231669.
    PubMed     Abstract available


  34. ADDEPALLI A, Kalyani S, Singh M, Bandyopadhyay D, et al
    CalPen (Calculator of Penetrance), a web-based tool to estimate penetrance in complex genetic disorders.
    PLoS One. 2020;15:e0228156.
    PubMed     Abstract available


  35. GOUGH N, Brkan L, Subramaniam P, Chiuccariello L, et al
    Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
    PLoS One. 2020;15:e0223029.
    PubMed     Abstract available


  36. LEE DK, Lee H, Park K, Joh E, et al
    Common gray and white matter abnormalities in schizophrenia and bipolar disorder.
    PLoS One. 2020;15:e0232826.
    PubMed     Abstract available


  37. DEBAVEYE S, De Smedt D, Heirman B, Kavanagh S, et al
    Quantifying the handprint-Footprint balance into a single score: The example of pharmaceuticals.
    PLoS One. 2020;15:e0229235.
    PubMed     Abstract available


  38. LEE J, Green MF, Nuechterlein KH, Swerdlow NR, et al
    The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study.
    PLoS One. 2020;15:e0232855.
    PubMed     Abstract available


  39. DEHELEAN L, Romosan AM, Papava I, Bredicean CA, et al
    Prolactin response to antipsychotics: An inpatient study.
    PLoS One. 2020;15:e0228648.
    PubMed     Abstract available


  40. BARTH C, Lonning V, Gurholt TP, Andreassen OA, et al
    Exploring white matter microstructure and the impact of antipsychotics in adolescent-onset psychosis.
    PLoS One. 2020;15:e0233684.
    PubMed     Abstract available


  41. MORUP MF, Kymes SM, Oudin Astrom D
    A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States.
    PLoS One. 2020;15:e0234121.
    PubMed     Abstract available


  42. DONEGAN JJ, Boley AM, Glenn JP, Carless MA, et al
    Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia.
    PLoS One. 2020;15:e0232200.
    PubMed     Abstract available


  43. BAN KY, Osborn DPJ, Hameed Y, Pandey S, et al
    Personality disorder in an Early Intervention Psychosis cohort: Findings from the Social Epidemiology of Psychoses in East Anglia (SEPEA) study.
    PLoS One. 2020;15:e0234047.
    PubMed     Abstract available


  44. HINOJOSA-MARQUES L, Dominguez-Martinez T, Kwapil TR, Barrantes-Vidal N, et al
    Predictors of criticism and emotional over-involvement in relatives of early psychosis patients.
    PLoS One. 2020;15:e0234325.
    PubMed     Abstract available


  45. HUANG PS, Chen CL, Yeung KT, Hsu MY, et al
    Effects of different types of sensory signals on reaching performance in persons with chronic schizophrenia.
    PLoS One. 2020;15:e0234976.
    PubMed     Abstract available


  46. DREGAN A, McNeill A, Gaughran F, Jones PB, et al
    Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom.
    PLoS One. 2020;15:e0230674.
    PubMed     Abstract available


  47. JIN H, Tappenden P, Robinson S, Achilla E, et al
    Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia.
    PLoS One. 2020;15:e0234996.
    PubMed     Abstract available


  48. VIDAL-DOMENECH F, Riquelme G, Pinacho R, Rodriguez-Mias R, et al
    Calcium-binding proteins are altered in the cerebellum in schizophrenia.
    PLoS One. 2020;15:e0230400.
    PubMed     Abstract available


  49. SVENDSEN IH, Oie MG, Moller P, Nelson B, et al
    Basic self-disturbances are associated with Sense of Coherence in patients with psychotic disorders.
    PLoS One. 2020;15:e0230956.
    PubMed     Abstract available


  50. JO M, Kim HJ, Rim SJ, Lee MG, et al
    The cost-of-illness trend of schizophrenia in South Korea from 2006 to 2016.
    PLoS One. 2020;15:e0235736.
    PubMed     Abstract available


  51. DOR-NEDONSEL E, Menard ML, Fernandez A, Sakarovitch C, et al
    Early-Onset Schizophrenia in a paediatric population of French psychiatric and medico-social care centres: A cross sectional study.
    PLoS One. 2020;15:e0236241.
    PubMed     Abstract available


  52. LUCAS-MOLINA B, Perez-Albeniz A, Satorres E, Ortuno-Sierra J, et al
    Identifying extended psychosis phenotypes at school: Associations with socio-emotional adjustment, academic, and neurocognitive outcomes.
    PLoS One. 2020;15:e0237968.
    PubMed     Abstract available


  53. HENSON P, Pearson JF, Keshavan M, Torous J, et al
    Impact of dynamic greenspace exposure on symptomatology in individuals with schizophrenia.
    PLoS One. 2020;15:e0238498.
    PubMed     Abstract available


  54. MAHAR AL, Kurdyak P, Hanna TP, Coburn NG, et al
    The effect of a severe psychiatric illness on colorectal cancer treatment and survival: A population-based retrospective cohort study.
    PLoS One. 2020;15:e0235409.
    PubMed     Abstract available


  55. KITAGAWA K, So R, Nomura N, Mizuno Y, et al
    Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J).
    PLoS One. 2020;15:e0234864.
    PubMed     Abstract available


  56. LEE Y, Kim SK, Eom MR
    Usability of mental illness simulation involving scenarios with patients with schizophrenia via immersive virtual reality: A mixed methods study.
    PLoS One. 2020;15:e0238437.
    PubMed     Abstract available


  57. RAMCHANDRAN K, Fiedorowicz J, Chen Z, Bu Y, et al
    Patients on the psychosis spectrum employ an alternate brain network to engage in complex decision-making.
    PLoS One. 2020;15:e0238774.
    PubMed     Abstract available


  58. JOHANSSON KA, Okland JM, Skaftun EK, Bukhman G, et al
    Estimating Health Adjusted Age at Death (HAAD).
    PLoS One. 2020;15:e0235955.
    PubMed     Abstract available


  59. KUMSA A, Agenagnew L, Alemu B, Girma S, et al
    Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic.
    PLoS One. 2020;15:e0235365.
    PubMed     Abstract available


  60. YAMAZAKI M, Honda S, Tamaki K, Irie M, et al
    Effects of (+)-bicuculline, a GABAa receptor antagonist, on auditory steady state response in free-moving rats.
    PLoS One. 2020;15:e0236363.
    PubMed     Abstract available


  61. ISHII J, Kodaka F, Miyata H, Yamadera W, et al
    Associations between parental bonding during childhood and functional recovery in patients with schizophrenia.
    PLoS One. 2020;15:e0240504.
    PubMed     Abstract available


  62. FUJII K, Yoshihara Y, Matsumoto Y, Tose K, et al
    Cognition and interpersonal coordination of patients with schizophrenia who have sports habits.
    PLoS One. 2020;15:e0241863.
    PubMed     Abstract available


  63. IZAUTE M, Thuaire F, Meot A, Rondepierre F, et al
    Metacognitive preserved generation strategy benefits for both younger and elderly participants with schizophrenia.
    PLoS One. 2020;15:e0241356.
    PubMed     Abstract available


  64. TORREY EF, Knable MB, Rush AJ, Simmons WW, et al
    Using the NIH Research, Condition and Disease Categorization Database for research advocacy: Schizophrenia research at NIMH as an example.
    PLoS One. 2020;15:e0241062.
    PubMed     Abstract available


  65. YAMAMOTO M, Bagarinao E, Kushima I, Takahashi T, et al
    Support vector machine-based classification of schizophrenia patients and healthy controls using structural magnetic resonance imaging from two independent sites.
    PLoS One. 2020;15:e0239615.
    PubMed     Abstract available


  66. ALAMEDA L, Levier A, Gholam-Rezaee M, Golay P, et al
    Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication.
    PLoS One. 2020;15:e0242569.
    PubMed     Abstract available


  67. LIM K, Lam M, Huang H, Liu J, et al
    Genetic liability in individuals at ultra-high risk of psychosis: A comparison study of 9 psychiatric traits.
    PLoS One. 2020;15:e0243104.
    PubMed     Abstract available


  68. BIRNBAUM ML, Wen H, Van Meter A, Ernala SK, et al
    Identifying emerging mental illness utilizing search engine activity: A feasibility study.
    PLoS One. 2020;15:e0240820.
    PubMed     Abstract available


  69. CHAFI YK, Amare T, Haile K, Damene W, et al
    Prevalence and correlates of job loss among schizophrenia outpatients at St. AmanuelMental Specialized Hospital, Addis Ababa, Ethiopia; cross sectional study.
    PLoS One. 2020;15:e0242352.
    PubMed     Abstract available


  70. IQBAL E, Govind R, Romero A, Dzahini O, et al
    The side effect profile of Clozapine in real world data of three large mental health hospitals.
    PLoS One. 2020;15:e0243437.
    PubMed     Abstract available


    January 2019
  71. O'NEILL B, Kalia S, Aliarzadeh B, Moineddin R, et al
    Agreement between primary care and hospital diagnosis of schizophrenia and bipolar disorder: A cross-sectional, observational study using record linkage.
    PLoS One. 2019;14:e0210214.
    PubMed     Abstract available


  72. FELTRIN AS, Tahira AC, Simoes SN, Brentani H, et al
    Assessment of complementarity of WGCNA and NERI results for identification of modules associated to schizophrenia spectrum disorders.
    PLoS One. 2019;14:e0210431.
    PubMed     Abstract available


  73. LADO-CODESIDO M, Mendez Perez C, Mateos R, Olivares JM, et al
    Improving emotion recognition in schizophrenia with "VOICES": An on-line prosodic self-training.
    PLoS One. 2019;14:e0210816.
    PubMed     Abstract available


  74. CHIOU YJ, Huang TL
    Accuracy of brain-derived neurotrophic factor levels for differentiating between Taiwanese patients with major depressive disorder or schizophrenia and healthy controls.
    PLoS One. 2019;14:e0212373.
    PubMed     Abstract available


  75. SCHEPERS E, van Os J, Lousberg R
    White noise speech illusions in the general population: The association with psychosis expression and risk factors for psychosis.
    PLoS One. 2019;14:e0211914.
    PubMed     Abstract available


  76. MARTIN EA, Castro MK, Li LY, Urban EJ, et al
    Emotional response in schizophrenia to the "36 questions that lead to love": Predicted and experienced emotions regarding a live social interaction.
    PLoS One. 2019;14:e0212069.
    PubMed     Abstract available


  77. LEIGHTON SP, Krishnadas R, Chung K, Blair A, et al
    Predicting one-year outcome in first episode psychosis using machine learning.
    PLoS One. 2019;14:e0212846.
    PubMed     Abstract available


  78. CRESPO Y, Ibanez A, Soriano MF, Iglesias S, et al
    Handwriting movements for assessment of motor symptoms in schizophrenia spectrum disorders and bipolar disorder.
    PLoS One. 2019;14:e0213657.
    PubMed     Abstract available


  79. TAHIR Y, Yang Z, Chakraborty D, Thalmann N, et al
    Non-verbal speech cues as objective measures for negative symptoms in patients with schizophrenia.
    PLoS One. 2019;14:e0214314.
    PubMed     Abstract available


  80. KIRINO E, Hayakawa Y, Inami R, Inoue R, et al
    Simultaneous fMRI-EEG-DTI recording of MMN in patients with schizophrenia.
    PLoS One. 2019;14:e0215023.
    PubMed     Abstract available


  81. LEE J, Jimenez AM, Horan WP, Green MF, et al
    fMRI biomarkers of social cognitive skills training in psychosis: Extrinsic and intrinsic functional connectivity.
    PLoS One. 2019;14:e0214303.
    PubMed     Abstract available


  82. PINTO DA COSTA M, Chevalier A, Farreny A, Cassidy M, et al
    How would patients with psychosis like to be in contact with a volunteer: Face-to-face or digitally?
    PLoS One. 2019;14:e0216929.
    PubMed     Abstract available


  83. CHEN WY, Chen LY, Liu HC, Wu CS, et al
    Correction: Antipsychotic medications and stroke in schizophrenia: A case-crossover study.
    PLoS One. 2019;14:e0217323.
    PubMed     Abstract available


  84. NUNO L, Guilera G, Coenen M, Rojo E, et al
    Functioning in schizophrenia from the perspective of psychologists: A worldwide study.
    PLoS One. 2019;14:e0217936.
    PubMed     Abstract available


  85. COKAL D, Zimmerer V, Turkington D, Ferrier N, et al
    Disturbing the rhythm of thought: Speech pausing patterns in schizophrenia, with and without formal thought disorder.
    PLoS One. 2019;14:e0217404.
    PubMed     Abstract available


  86. ROBOL V, Tibber MS, Anderson EJ, Bobin T, et al
    Correction: Reduced Crowding and Poor Contour Detection in Schizophrenia Are Consistent with Weak Surround Inhibition.
    PLoS One. 2019;14:e0218483.
    PubMed     Abstract available


  87. TIBBER MS, Anderson EJ, Bobin T, Carlin P, et al
    Correction: Local and Global Limits on Visual Processing in Schizophrenia.
    PLoS One. 2019;14:e0218466.
    PubMed     Abstract available


  88. COUNOTTE J, Bergink V, Pot-Kolder R, Drexhage HA, et al
    Inflammatory cytokines and growth factors were not associated with psychosis liability or childhood trauma.
    PLoS One. 2019;14:e0219139.
    PubMed     Abstract available


  89. STEPANOVA EV, Kondrashin AV, Sergiev VP, Morozova LF, et al
    Toxoplasmosis and mental disorders in the Russian Federation (with special reference to schizophrenia).
    PLoS One. 2019;14:e0219454.
    PubMed     Abstract available


  90. KIDD SA, Feldcamp L, Adler A, Kaleis L, et al
    Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: App4Independence (A4i).
    PLoS One. 2019;14:e0219491.
    PubMed     Abstract available


  91. ARAKAWA Y, Yokoyama K, Tasaki S, Kato J, et al
    Transgenic mice overexpressing miR-137 in the brain show schizophrenia-associated behavioral deficits and transcriptome profiles.
    PLoS One. 2019;14:e0220389.
    PubMed     Abstract available


  92. WYNN JK, Engel SA, Lee J, Reavis EA, et al
    Evidence for intact stimulus-specific neural adaptation for visual objects in schizophrenia and bipolar disorder: An ERP study.
    PLoS One. 2019;14:e0221409.
    PubMed     Abstract available


  93. VAN DER LEE APM, de Haan L, Beekman ATF
    Rising co-payments coincide with unwanted effects on continuity of healthcare for patients with schizophrenia in the Netherlands.
    PLoS One. 2019;14:e0222046.
    PubMed     Abstract available


  94. ROOSENSCHOON BJ, Kamperman AM, Deen ML, Weeghel JV, et al
    Determinants of clinical, functional and personal recovery for people with schizophrenia and other severe mental illnesses: A cross-sectional analysis.
    PLoS One. 2019;14:e0222378.
    PubMed     Abstract available


  95. LI F, Sabunciyan S, Yolken RH, Lee D, et al
    Transcription of human endogenous retroviruses in human brain by RNA-seq analysis.
    PLoS One. 2019;14:e0207353.
    PubMed     Abstract available


  96. GASTALDON C, Mosler F, Toner S, Tedeschi F, et al
    Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review.
    PLoS One. 2019;14:e0222891.
    PubMed     Abstract available


  97. MOTE J, Gard DE, Gonzalez R, Fulford D, et al
    How did that interaction make you feel? The relationship between quality of everyday social experiences and emotion in people with and without schizophrenia.
    PLoS One. 2019;14:e0223003.
    PubMed     Abstract available


  98. HINOJOSA-MARQUES L, Dominguez-Martinez T, Sheinbaum T, Cristobal-Narvaez P, et al
    Relatives' attachment anxiety mediates the association between perceived loss and expressed emotion in early psychosis.
    PLoS One. 2019;14:e0223425.
    PubMed     Abstract available


  99. YOKOYAMA K, Morimoto T, Ichihara-Takeda S, Yoshino J, et al
    Relationship between self-disclosure to first acquaintances and subjective well-being in people with schizophrenia spectrum disorders living in the community.
    PLoS One. 2019;14:e0223819.
    PubMed     Abstract available


  100. REKHI G, Ang MS, Lee J
    Clinical determinants of social media use in individuals with schizophrenia.
    PLoS One. 2019;14:e0225370.
    PubMed     Abstract available



  101. Correction: Relationship between self-disclosure to first acquaintances and subjective well-being in people with schizophrenia spectrum disorders living in the community.
    PLoS One. 2019;14:e0225680.
    PubMed     Abstract available


  102. YOLKEN R, Stallings C, Origoni A, Katsafanas E, et al
    Exposure to household pet cats and dogs in childhood and risk of subsequent diagnosis of schizophrenia or bipolar disorder.
    PLoS One. 2019;14:e0225320.
    PubMed     Abstract available


  103. MARTINEZ A, Ibarra IA, Vargas R
    A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease.
    PLoS One. 2019;14:e0224691.
    PubMed     Abstract available


  104. MILLER RL, Pearlson G, Calhoun VD
    Whole brain polarity regime dynamics are significantly disrupted in schizophrenia and correlate strongly with network connectivity measures.
    PLoS One. 2019;14:e0224744.
    PubMed     Abstract available


  105. LOPEZ-DEL-HOYO Y, Panzano MG, Lahera G, Herrera-Mercadal P, et al
    Differences between individuals with schizophrenia or obsessive-compulsive disorder and healthy controls in social cognition and mindfulness skills: A controlled study.
    PLoS One. 2019;14:e0225608.
    PubMed     Abstract available


  106. FAN ZL, Wu B, Wu GY, Yao J, et al
    Optogenetic inhibition of ventral hippocampal neurons alleviates associative motor learning dysfunction in a rodent model of schizophrenia.
    PLoS One. 2019;14:e0227200.
    PubMed     Abstract available


  107. GADIN JR, Buil A, Colantuoni C, Jaffe AE, et al
    Comparison of quantitative trait loci methods: Total expression and allelic imbalance method in brain RNA-seq.
    PLoS One. 2019;14:e0217765.
    PubMed     Abstract available


  108. CHASE KA, Feiner B, Ramaker MJ, Hu E, et al
    Examining the effects of the histone methyltransferase inhibitor BIX-01294 on histone modifications and gene expression in both a clinical population and mouse models.
    PLoS One. 2019;14:e0216463.
    PubMed     Abstract available


  109. LOUGHLIN AM, Lin N, Abler V, Carroll B, et al
    Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States.
    PLoS One. 2019;14:e0216044.
    PubMed     Abstract available


  110. TAKACS P, Czobor P, Feher L, Gimesi-Orszagh J, et al
    Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary.
    PLoS One. 2019;14:e0218071.
    PubMed     Abstract available


  111. FERNANDEZ-SOTOS P, Torio I, Fernandez-Caballero A, Navarro E, et al
    Social cognition remediation interventions: A systematic mapping review.
    PLoS One. 2019;14:e0218720.
    PubMed     Abstract available


  112. REES JMB, Wood AM, Dudbridge F, Burgess S, et al
    Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates.
    PLoS One. 2019;14:e0222362.
    PubMed     Abstract available


  113. PROCHNICKI M, Rudzki G, Dzikowski M, Jaroszynski A, et al
    The impact of electroconvulsive therapy on the spatial QRS-T angle and cardiac troponin T concentration in psychiatric patients.
    PLoS One. 2019;14:e0224020.
    PubMed     Abstract available


    January 2018
  114. MONACO A, Monda A, Amoroso N, Bertolino A, et al
    A complex network approach reveals a pivotal substructure of genes linked to schizophrenia.
    PLoS One. 2018;13:e0190110.
    PubMed     Abstract available


  115. KOBAYASHI M, Jitoku D, Iwayama Y, Yamamoto N, et al
    Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.
    PLoS One. 2018;13:e0190991.
    PubMed     Abstract available


  116. YERABHAM ASK, Muller-Schiffmann A, Ziehm T, Stadler A, et al
    Biophysical insights from a single chain camelid antibody directed against the Disrupted-in-Schizophrenia 1 protein.
    PLoS One. 2018;13:e0191162.
    PubMed     Abstract available


  117. PALACIOS-CENA D, Martin-Tejedor EA, Elias-Elispuru A, Garate-Samaniego A, et al
    The impact of a short-term cohousing initiative among schizophrenia patients, high school students, and their social context: A qualitative case study.
    PLoS One. 2018;13:e0190895.
    PubMed     Abstract available


  118. GONCALVES VF, Giamberardino SN, Crowley JJ, Vawter MP, et al
    Examining the role of common and rare mitochondrial variants in schizophrenia.
    PLoS One. 2018;13:e0191153.
    PubMed     Abstract available


  119. GUO S, Huang CC, Zhao W, Yang AC, et al
    Combining multi-modality data for searching biomarkers in schizophrenia.
    PLoS One. 2018;13:e0191202.
    PubMed     Abstract available


  120. GONZALEZ DE ARTAZA M, Catalan A, Angosto V, Valverde C, et al
    Can an experimental white noise task assess psychosis vulnerability in adult healthy controls?
    PLoS One. 2018;13:e0192373.
    PubMed     Abstract available


  121. VAESSEN TSJ, de Jong L, Schafer AT, Damen T, et al
    The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta - analysis.
    PLoS One. 2018;13:e0192658.
    PubMed     Abstract available


  122. CHIU CC, Lu ML, Huang MC, Chen PY, et al
    Correction: Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study.
    PLoS One. 2018;13:e0193315.
    PubMed     Abstract available


  123. SCHOTTLE D, Schimmelmann BG, Ruppelt F, Bussopulos A, et al
    Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia-spectrum and bipolar I disorders: Four-year follow-up of the ACCESS II study.
    PLoS One. 2018;13:e0192929.
    PubMed     Abstract available


  124. MANLEY W, Moreau MP, Azaro M, Siecinski SK, et al
    Validation of a microRNA target site polymorphism in H3F3B that is potentially associated with a broad schizophrenia phenotype.
    PLoS One. 2018;13:e0194233.
    PubMed     Abstract available


  125. EGLIT GML, Palmer BW, Martin AS, Tu X, et al
    Loneliness in schizophrenia: Construct clarification, measurement, and clinical relevance.
    PLoS One. 2018;13:e0194021.
    PubMed     Abstract available


  126. SBISA A, van den Buuse M, Gogos A
    The effect of estrogenic compounds on psychosis-like behaviour in female rats.
    PLoS One. 2018;13:e0193853.
    PubMed     Abstract available


  127. SHIMADA T, Ohori M, Inagaki Y, Shimooka Y, et al
    A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.
    PLoS One. 2018;13:e0193869.
    PubMed     Abstract available


  128. FASMER EE, Fasmer OB, Berle JO, Oedegaard KJ, et al
    Graph theory applied to the analysis of motor activity in patients with schizophrenia and depression.
    PLoS One. 2018;13:e0194791.
    PubMed     Abstract available


  129. GARCIA S, Alberich S, Martinez-Cengotitabengoa M, Arango C, et al
    The complex association between the antioxidant defense system and clinical status in early psychosis.
    PLoS One. 2018;13:e0194685.
    PubMed     Abstract available


  130. EGLOFF L, Studerus E, Zimmermann R, Heitz U, et al
    Evaluating verbal learning and memory in patients with an at-risk mental state or first episode psychosis using structural equation modelling.
    PLoS One. 2018;13:e0196936.
    PubMed     Abstract available


  131. GISSELGARD J, Lebedev AV, Daehli Kurz K, Joa I, et al
    Structural and functional alterations in the brain during working memory in medication-naive patients at clinical high-risk for psychosis.
    PLoS One. 2018;13:e0196289.
    PubMed     Abstract available


  132. RASSOVSKY Y, Dunn W, Wynn JK, Wu AD, et al
    Single transcranial direct current stimulation in schizophrenia: Randomized, cross-over study of neurocognition, social cognition, ERPs, and side effects.
    PLoS One. 2018;13:e0197023.
    PubMed     Abstract available


  133. KANCHANATAWAN B, Tangwongchai S, Supasitthumrong T, Sriswasdi S, et al
    Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment.
    PLoS One. 2018;13:e0197004.
    PubMed     Abstract available


  134. KAGEYAMA M, Solomon P
    Post-traumatic stress disorder in parents of patients with schizophrenia following familial violence.
    PLoS One. 2018;13:e0198164.
    PubMed     Abstract available


  135. TORDESILLAS-GUTIERREZ D, Ayesa-Arriola R, Delgado-Alvarado M, Robinson JL, et al
    The right occipital lobe and poor insight in first-episode psychosis.
    PLoS One. 2018;13:e0197715.
    PubMed     Abstract available


  136. ZHANG T, Li J, Yu H, Shi Y, et al
    Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium.
    PLoS One. 2018;13:e0198690.
    PubMed     Abstract available


  137. STEPIEN M, Manoliu A, Kubli R, Schneider K, et al
    Investigating the association of ventral and dorsal striatal dysfunction during reward anticipation with negative symptoms in patients with schizophrenia and healthy individuals.
    PLoS One. 2018;13:e0198215.
    PubMed     Abstract available


  138. KAWAKUBO Y, Yanagi M, Tsujii N, Shirakawa O, et al
    Repetition of verbal fluency task attenuates the hemodynamic activation in the left prefrontal cortex: Enhancing the clinical usefulness of near-infrared spectroscopy.
    PLoS One. 2018;13:e0193994.
    PubMed     Abstract available


  139. GUPTA P, Uner OE, Nayak S, Grant GR, et al
    SAP97 regulates behavior and expression of schizophrenia risk enriched gene sets in mouse hippocampus.
    PLoS One. 2018;13:e0200477.
    PubMed     Abstract available


  140. DAVIS KAS, Bashford O, Jewell A, Shetty H, et al
    Using data linkage to electronic patient records to assess the validity of selected mental health diagnoses in English Hospital Episode Statistics (HES).
    PLoS One. 2018;13:e0195002.
    PubMed     Abstract available


  141. TAJIRI M, Suzuki Y, Sugai T, Tsuneyama N, et al
    Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia.
    PLoS One. 2018;13:e0199922.
    PubMed     Abstract available


  142. FUJITO NT, Satta Y, Hane M, Matsui A, et al
    Positive selection on schizophrenia-associated ST8SIA2 gene in post-glacial Asia.
    PLoS One. 2018;13:e0200278.
    PubMed     Abstract available


  143. BERRY S, Weinmann O, Fritz AK, Rust R, et al
    Loss of Nogo-A, encoded by the schizophrenia risk gene Rtn4, reduces mGlu3 expression and causes hyperexcitability in hippocampal CA3 circuits.
    PLoS One. 2018;13:e0200896.
    PubMed     Abstract available


  144. LEE LHN, Procyshyn RM, White RF, Woodward TS, et al
    Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.
    PLoS One. 2018;13:e0199758.
    PubMed     Abstract available


  145. BERG AO, Jorgensen KN, Nerhus M, Athanasiu L, et al
    Vitamin D levels, brain volume, and genetic architecture in patients with psychosis.
    PLoS One. 2018;13:e0200250.
    PubMed     Abstract available


  146. HEIBERG IH, Jacobsen BK, Nesvag R, Bramness JG, et al
    Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder.
    PLoS One. 2018;13:e0202028.
    PubMed     Abstract available


  147. BETTELLA F, Brown AA, Smeland OB, Wang Y, et al
    Cross-tissue eQTL enrichment of associations in schizophrenia.
    PLoS One. 2018;13:e0202812.
    PubMed     Abstract available


  148. JOO SW, Yoon W, Shon SH, Kim H, et al
    Altered white matter connectivity in patients with schizophrenia: An investigation using public neuroimaging data from SchizConnect.
    PLoS One. 2018;13:e0205369.
    PubMed     Abstract available


  149. SHIMADA T, Ohori M, Inagaki Y, Shimooka Y, et al
    Correction: A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.
    PLoS One. 2018;13:e0205549.
    PubMed     Abstract available


  150. RACIOPPI A, Sheinbaum T, Gross GM, Ballespi S, et al
    Prediction of prodromal symptoms and schizophrenia-spectrum personality disorder traits by positive and negative schizotypy: A 3-year prospective study.
    PLoS One. 2018;13:e0207150.
    PubMed     Abstract available


  151. OISHI K, Kanahara N, Takase M, Oda Y, et al
    Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.
    PLoS One. 2018;13:e0207133.
    PubMed     Abstract available


  152. WIJNEN BFM, Pos K, Velthorst E, Schirmbeck F, et al
    Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis.
    PLoS One. 2018;13:e0206236.
    PubMed     Abstract available


  153. SPILSBURY K, Rosenwax L, Brameld K, Kelly B, et al
    Morbidity burden and community-based palliative care are associated with rates of hospital use by people with schizophrenia in the last year of life: A population-based matched cohort study.
    PLoS One. 2018;13:e0208220.
    PubMed     Abstract available


  154. HOFFMANN C, Stevens J, Zong S, van Kruining D, et al
    Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder.
    PLoS One. 2018;13:e0208412.
    PubMed     Abstract available


  155. JIANG WJ, Zhong BL, Liu LZ, Zhou YJ, et al
    Reliability and validity of the Chinese version of the Childhood Trauma Questionnaire-Short Form for inpatients with schizophrenia.
    PLoS One. 2018;13:e0208779.
    PubMed     Abstract available


  156. HAGEN CM, Goncalves VF, Hedley PL, Bybjerg-Grauholm J, et al
    Schizophrenia-associated mt-DNA SNPs exhibit highly variable haplogroup affiliation and nuclear ancestry: Bi-genomic dependence raises major concerns for link to disease.
    PLoS One. 2018;13:e0208828.
    PubMed     Abstract available


  157. STEENHUIS LA, Nauta MH, Bockting CLH, Pijnenborg GHM, et al
    Correction: Treating Depressive Symptoms in Psychosis: A Network Meta-Analysis on the Effects of Non-Verbal Therapies.
    PLoS One. 2018;13:e0209762.
    PubMed     Abstract available


  158. OSTUZZI G, Mazzi MA, Terlizzi S, Bertolini F, et al
    Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy.
    PLoS One. 2018;13:e0201371.
    PubMed     Abstract available


  159. SEVILLA G, Rossello J, Salvador R, Sarro S, et al
    Deficits in nominal reference identify thought disordered speech in a narrative production task.
    PLoS One. 2018;13:e0201545.
    PubMed     Abstract available


  160. DREWS HJ, Wiesner CD, Bethke-Jaenicke C, Weinhold SL, et al
    Slow-wave sleep predicts long-term social functioning in severe mental illness.
    PLoS One. 2018;13:e0202198.
    PubMed     Abstract available


    January 2017
  161. MOHITE S, Yang F, Amin PA, Zunta-Soares G, et al
    Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls.
    PLoS One. 2017;12:e0174073.
    PubMed     Abstract available


  162. WANG WC, Lu ML, Chen VC, Ng MH, et al
    Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in Taiwan.
    PLoS One. 2017;12:e0173063.
    PubMed     Abstract available


  163. GUO W, Cai Y, Zhang H, Yang Y, et al
    Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population.
    PLoS One. 2017;12:e0175209.
    PubMed     Abstract available


  164. RIVOLLIER F, Chaumette B, Bendjemaa N, Chayet M, et al
    Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrol.
    PLoS One. 2017;12:e0174783.
    PubMed     Abstract available


  165. ARMANDO M, Schneider M, Pontillo M, Vicari S, et al
    No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?
    PLoS One. 2017;12:e0174797.
    PubMed     Abstract available


  166. SALVADOR R, Radua J, Canales-Rodriguez EJ, Solanes A, et al
    Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis.
    PLoS One. 2017;12:e0175683.
    PubMed     Abstract available


  167. CALETTI E, Marotta G, Del Vecchio G, Paoli RA, et al
    The metabolic basis of cognitive insight in psychosis: A positron emission tomography study.
    PLoS One. 2017;12:e0175803.
    PubMed     Abstract available


  168. HOWELL KR, Floyd K, Law AJ
    PKBgamma/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT/mTORC2 signaling: Relevance for schizophrenia.
    PLoS One. 2017;12:e0175993.
    PubMed     Abstract available


  169. KIM GW, Kim YH, Jeong GW
    Whole brain volume changes and its correlation with clinical symptom severity in patients with schizophrenia: A DARTEL-based VBM study.
    PLoS One. 2017;12:e0177251.
    PubMed     Abstract available


  170. LIU H, Li L, Shen L, Wang X, et al
    Cavum septum pellucidum and first-episode psychosis: A meta-analysis.
    PLoS One. 2017;12:e0177715.
    PubMed     Abstract available


  171. RANDALL J, Chateau D, Bolton JM, Smith M, et al
    Increasing medication adherence and income assistance access for first-episode psychosis patients.
    PLoS One. 2017;12:e0179089.
    PubMed     Abstract available


  172. CONTRERAS F, Albacete A, Tebe C, Benejam B, et al
    Patients with schizophrenia activate behavioural intentions facilitated by counterfactual reasoning.
    PLoS One. 2017;12:e0178860.
    PubMed     Abstract available


  173. CHEN WY, Chen LY, Liu HC, Wu CS, et al
    Antipsychotic medications and stroke in schizophrenia: A case-crossover study.
    PLoS One. 2017;12:e0179424.
    PubMed     Abstract available


  174. YU Y, Liu ZW, Tang BW, Zhao M, et al
    Reported family burden of schizophrenia patients in rural China.
    PLoS One. 2017;12:e0179425.
    PubMed     Abstract available


  175. SQUARCINA L, Bellani M, Rossetti MG, Perlini C, et al
    Similar white matter changes in schizophrenia and bipolar disorder: A tract-based spatial statistics study.
    PLoS One. 2017;12:e0178089.
    PubMed     Abstract available


  176. BENOIT L, Moro MR, Falissard B, Henckes N, et al
    Psychosis risk research versus daily prognosis uncertainties: A qualitative study of French youth psychiatrists' attitudes toward predictive practices.
    PLoS One. 2017;12:e0179849.
    PubMed     Abstract available


  177. GIACOPUZZI E, Gennarelli M, Minelli A, Gardella R, et al
    Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways.
    PLoS One. 2017;12:e0182778.
    PubMed     Abstract available


  178. ATKINSON RJ, Fulham WR, Michie PT, Ward PB, et al
    Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.
    PLoS One. 2017;12:e0171657.
    PubMed     Abstract available


  179. TOYOMAKI A, Hashimoto N, Kako Y, Murohashi H, et al
    Neural responses to feedback information produced by self-generated or other-generated decision-making and their impairment in schizophrenia.
    PLoS One. 2017;12:e0183792.
    PubMed     Abstract available


  180. PINHEIRO DS, Santos RDS, de Brito RB, Cruz AHDS, et al
    GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients.
    PLoS One. 2017;12:e0183812.
    PubMed     Abstract available


  181. POTKIN SG, Loze JY, Forray C, Baker RA, et al
    Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
    PLoS One. 2017;12:e0183475.
    PubMed     Abstract available


  182. PRIES LK, Guloksuz S, Menne-Lothmann C, Decoster J, et al
    White noise speech illusion and psychosis expression: An experimental investigation of psychosis liability.
    PLoS One. 2017;12:e0183695.
    PubMed     Abstract available


  183. SETIEN-SUERO E, Neergaard K, Ramirez-Bonilla M, Correa-Ghisays P, et al
    Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences.
    PLoS One. 2017;12:e0183613.
    PubMed     Abstract available


  184. HAIMOVICH JS, Venkatesh AK, Shojaee A, Coppi A, et al
    Discovery of temporal and disease association patterns in condition-specific hospital utilization rates.
    PLoS One. 2017;12:e0172049.
    PubMed     Abstract available


  185. XU FL, Ding M, Yao J, Shi ZS, et al
    Association between mitochondrial DNA variations and schizophrenia in the northern Chinese Han population.
    PLoS One. 2017;12:e0182769.
    PubMed     Abstract available


  186. AFSHARI P, Yao WD, Middleton FA
    Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia.
    PLoS One. 2017;12:e0183854.
    PubMed     Abstract available


  187. ZAPRUTKO T, Kopciuch D, Kus K, Merks P, et al
    Affordability of medicines in the European Union.
    PLoS One. 2017;12:e0172753.
    PubMed     Abstract available


  188. PINSONNEAULT JK, Frater JT, Kompa B, Mascarenhas R, et al
    Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traits.
    PLoS One. 2017;12:e0179020.
    PubMed     Abstract available


  189. SULLIVAN S, Northstone K, Gadd C, Walker J, et al
    Models to predict relapse in psychosis: A systematic review.
    PLoS One. 2017;12:e0183998.
    PubMed     Abstract available


  190. DE CASTRO-CATALA M, Mora-Solano A, Kwapil TR, Cristobal-Narvaez P, et al
    The genome-wide associated candidate gene ZNF804A and psychosis-proneness: Evidence of sex-modulated association.
    PLoS One. 2017;12:e0185072.
    PubMed     Abstract available


  191. DECUYPERE F, Sermon J, Geerts P, Denee TR, et al
    Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
    PLoS One. 2017;12:e0179049.
    PubMed     Abstract available


  192. ERMAKOV EA, Smirnova LP, Bokhan NA, Semke AV, et al
    Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.
    PLoS One. 2017;12:e0183867.
    PubMed     Abstract available


  193. NAPOLITANO F, Booth Warren E, Migliarini S, Punzo D, et al
    Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
    PLoS One. 2017;12:e0181677.
    PubMed     Abstract available


  194. KANTOJARVI K, Liuhanen J, Saarenpaa-Heikkila O, Satomaa AL, et al
    Variants in calcium voltage-gated channel subunit Alpha1 C-gene (CACNA1C) are associated with sleep latency in infants.
    PLoS One. 2017;12:e0180652.
    PubMed     Abstract available


  195. WU Q, Luo X, Chen S, Qi C, et al
    Mental health literacy survey of non-mental health professionals in six general hospitals in Hunan Province of China.
    PLoS One. 2017;12:e0180327.
    PubMed     Abstract available


  196. DVEY-AHARON Z, Fogelson N, Peled A, Intrator N, et al
    Connectivity maps based analysis of EEG for the advanced diagnosis of schizophrenia attributes.
    PLoS One. 2017;12:e0185852.
    PubMed     Abstract available


  197. LEE H, Kim J
    Load-sensitive impairment of working memory for biological motion in schizophrenia.
    PLoS One. 2017;12:e0186498.
    PubMed     Abstract available


  198. JAKOBSEN AS, Speyer H, Norgaard HCB, Karlsen M, et al
    Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial.
    PLoS One. 2017;12:e0185881.
    PubMed     Abstract available


  199. ABDIN E, Chong SA, Vaingankar JA, Peh CX, et al
    Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.
    PLoS One. 2017;12:e0187141.
    PubMed     Abstract available


  200. HUNG YY, Chan HY, Pan YJ
    Risk factors for readmission in schizophrenia patients following involuntary admission.
    PLoS One. 2017;12:e0186768.
    PubMed     Abstract available


  201. DEANE AR, Millar J, Bilkey DK, Ward RD, et al
    Maternal immune activation in rats produces temporal perception impairments in adult offspring analogous to those observed in schizophrenia.
    PLoS One. 2017;12:e0187719.
    PubMed     Abstract available


  202. MAGGIONI E, Crespo-Facorro B, Nenadic I, Benedetti F, et al
    Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) study.
    PLoS One. 2017;12:e0188000.
    PubMed     Abstract available


  203. SHIMIZU N, Umemura T, Matsunaga M, Hirai T, et al
    An interactive sports video game as an intervention for rehabilitation of community-living patients with schizophrenia: A controlled, single-blind, crossover study.
    PLoS One. 2017;12:e0187480.
    PubMed     Abstract available



  204. Correction: Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
    PLoS One. 2017;12:e0188416.
    PubMed     Abstract available


  205. OLEJARCZYK E, Jernajczyk W
    Graph-based analysis of brain connectivity in schizophrenia.
    PLoS One. 2017;12:e0188629.
    PubMed     Abstract available


  206. MORERA-FUMERO AL, Diaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, et al
    A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia.
    PLoS One. 2017;12:e0189348.
    PubMed     Abstract available


  207. ATTAR R, Berg Johansen M, Valentin JB, Aagaard J, et al
    Treatment following myocardial infarction in patients with schizophrenia.
    PLoS One. 2017;12:e0189289.
    PubMed     Abstract available


  208. BAKIRHAN A, Yalcin Sahiner S, Sahiner IV, Safak Y, et al
    Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia.
    PLoS One. 2017;12:e0189373.
    PubMed     Abstract available


  209. CAMPBELL MM, Susser E, Mall S, Mqulwana SG, et al
    Using iterative learning to improve understanding during the informed consent process in a South African psychiatric genomics study.
    PLoS One. 2017;12:e0188466.
    PubMed     Abstract available


    January 2016
  210. SISKIND DJ, Leung J, Russell AW, Wysoczanski D, et al
    Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0156208.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: